Gene Query: ABHD17A

Dataset Description Geneva Score
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 36.68
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 36.68
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 29.36
DART-seq: an antibody-free method for global m6A detection 28.29
Intrahepatic MAIT cell gene expression revealed by RNA-seq 27.55
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 26.42
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 26.27
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 23.9
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 23.69
23.06
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 20.0
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 19.87
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 19.04
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 19.01
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 18.85
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 18.77
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 18.77
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 18.04
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 17.76
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 17.25
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 16.96
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 16.21
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 16.07
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 15.99
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 15.96
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 15.96
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 15.42
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 15.31
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 15.17
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 15.15
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 14.92
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 14.82
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 14.54
Transcriptome analysis of SKI knock-out in HL60 cells 14.54
Mutational landscape of splicing genes and functional consequences across 33 cancer types 14.38
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 14.21
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 13.55
Recovery and analysis of nascent RNA 13.37
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 13.37
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.31
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 13.29
Single-Cell Genotyping of Transcriptomes 13.21
RNA-seq of Single-Cell Genotyping of Transcriptomes 13.21
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 13.18
mRNA expression profile of Lymphocytes by high-throuput sequencing 13.16
Expression and functions of long noncoding RNAs during human T helper cell differentiation 12.98
High-Throughput Kinetic Analysis of Fractional Killing 12.8
RIG-I and MDA5 fRIP during KSHV lytic reactivation 12.77
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 12.71
Peptidomimetic blockade of MYB in acute myeloid leukemia 12.71
Gene expression profiling of leukemia cells following asparagine depletion 12.64
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 12.39
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 12.34
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 12.19
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.17
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 12.08
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 12.07
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 11.86
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 11.85
U1 snRNP telescripting regulates size-function stratified human genome 11.81
Stem and effector CD8 T-cells from human cancers 11.72
Hijacking of stress response machinery by oncogenes in acute leukaemia 11.71
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 11.71
Short and Long RNA sequencing of human mature erythrocytes 11.68
Gene expression signatures of innate lymphoid cells from human blood 11.67
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 11.63
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 11.63
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 11.54
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 11.49
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 11.46
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 11.45
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.34
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 11.28
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 11.28
SNHG5 siRNA knock down in HCT116 cells 11.01
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.84
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 10.73
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 10.61
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 10.59
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 10.57
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.54
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 10.52
CircRNAome diversity in human mature B-cells, T-cells and monocytes 10.47
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 10.4
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 10.4
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 10.31
METTL3 promotes translation in human cancer cells 10.17
Differentially expressed vascular development genes for iPSC-ECs from CDI 10.16
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 10.13
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 10.13
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 10.07
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 9.94
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 9.84
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.82
hTERT promotes cell adhesion and migration independent of telomerase activity 9.75
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 9.6
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 9.57
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.57
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.57
Gene expression changes caused by KRAS in MCF-10A 9.49
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.44
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 9.41
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 9.2
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 9.18
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 9.16
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.12
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.06
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.06
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 8.93
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 8.92
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.92
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 8.89
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 8.89
LNCaP treated with iBET 8.86
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.8
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 8.79
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 8.75
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 8.74
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.73
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.71
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.69
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 8.59
Transcriptome of U251 cells overexpression complement component 7 8.57
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 8.55
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 8.55
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 8.5
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 8.45
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 8.45
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 8.45
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 8.42
RNA-seq of cells with TET1 knockout 8.29
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 8.21
CROP-Seq in Primary Human T Cells 8.19
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.17
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.17
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.16
Cleavage Factor Im as a key regulator of 3’ UTR length 8.12
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 8.11
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 8.11
ARID1A and ARID1B loss in HCT116 and TOV21G cells 8.08
CHCHD10 gene KO effect in iPSC drived motor neurons 8.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 8.03
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 8.03
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 8.03
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 8.0
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.95
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 7.94
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.91
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 7.9
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 7.89
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.82
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 7.81
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 7.8
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 7.8
Active translatome profiling with RiboLace in MCF7 cells 7.79
LncRNA expression profiling of ischemic stroke patients 7.76
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 7.74
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 7.72
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 7.72
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 7.68
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 7.61
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 7.6
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.6
High-throughput sequencing of pluripotent cells 7.59
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.53
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 7.48
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 7.43
ARID1A and ARID1B loss in HCT116 cells 7.38
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 7.33
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.3
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 7.15
Transcriptome Profiling of Human Primary Monocytes 7.11
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.07
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 7.06
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 7.06
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.98
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 6.95
MARS Seq data from human cortical organoids 6.92
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.9
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 6.89
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 6.83
The human blood-nerve barrier transcriptome 6.81
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.71
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 6.71
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 6.7
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 6.68
circRNA-sequencing 6.64
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 6.64
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 6.58
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 6.58
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 6.57
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 6.54
Neonatal and adult human testis defined at the single-cell level 6.51
Gene Expression Profiling of SPOP Knocked Down Cell 6.46
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.44
STRIPAK directs PP2A activity to promote oncogenic transformation 6.4
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.4
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.4
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.39
Analysis of transcriptional regulation by Myt1 and Myt1l 6.34
Crizotinib v. DMSO in SW480 cells 6.33
Paxillin regulates genomic networks in prostate cancer [C4-2] 6.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma 6.29
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 6.24
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 6.24
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 6.17
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 6.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 6.15
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.11
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 6.11
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 6.11
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 6.11
RNA splicing alteration on glioblastoma and normal neural stem cells 6.09
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 6.07
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.06
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.06
Transciptomic profiling of human fetal lung samples 6.03
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 5.95
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 5.93
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.91
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 5.89
Differential responses of human fetal brain neural stem cells to Zika virus infection 5.86
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 5.78
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.75
RNA-Seq with and without RNase treatment in PCa cell lines 5.72
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 5.72
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.69
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.69
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.63
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.61
Transcriptome of Stabilin-1 siRNA transfected human monocytes 5.56
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 5.56
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.55
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 5.54
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.48
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.48
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 5.46
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 5.43
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.42
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 5.41
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 5.32
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 5.27
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 5.24
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.24
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.24
Role of XRN2 ribonucleolytic activity in RNA metabolism 5.23
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.22
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.18
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 5.15
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.13
Regulation of poly(A) tail and translation during the somatic cell cycle 5.11
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.07
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 5.05
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.02
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.0
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.99
Studying the selectivity of a small molecule Synucleozid on transcriptome 4.92
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.83
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.83
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.62
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.62
Functional role of CPPED1 in trophoblasts. 4.55
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.53
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.51
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.5
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 4.48
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 4.47
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.41
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.3
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 4.29
Genome-wide discovery of human splicing branchpoints 4.26
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.26
Global response to chemotherapy-induced apoptosis 4.22
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 4.2
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.2
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 4.16
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.12
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 4.08
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.08
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.08
Effect of ILF3 on translation during homeostasis and the antiviral response 4.05
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.0
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 3.99
PRDM1 inhibits proliferation of human colon cancer organoids 3.94
Universal alternative splicing of noncoding exons 3.94
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.92
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.92
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.91
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.89
Transcriptome of activated human and mouse MAIT cells 3.89
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 3.86
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 3.83
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.82
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.8
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.75
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.71
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 3.68
Targeted enhancer activation by a subunit of the integrator complex 3.6
Ribosomal protein RPL26 is the principal target of UFMylation 3.6
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 3.58
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.53
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.53
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.53
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.52
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.51
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.49
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.49
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.49
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 3.47
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.44
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 3.44
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.35
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 3.34
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 3.34
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.33
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.28
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 3.23
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 3.22
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 3.22
X-Ray induced DNA-Hydroxymethylation changes 3.22
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 3.16
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.16
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.15
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.13
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.13
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.11
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.11
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 3.08
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.07
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.06
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 3.01
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 3.01
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 3.0
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.96
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.96
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.93
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 2.91
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.89
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.88
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.88
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.84
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.84
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.8
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.77
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.77
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.77
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.76
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 2.76
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 2.76
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.73
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.72
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.72
Metastasis in triple-negative breast cancer 2.68
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.68
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.68
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.65
RNA-seq analysis upon ARID1B overexpression 2.62
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.62
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.61
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.61
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.57
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.54
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.54
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.54
Transcriptomic analysis of LSD1 2.54
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.52
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.52
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.51
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.47
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.46
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.43
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.43
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.43
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.43
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.42
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.41
Transcriptomes in healthy and CHB fetal hearts 2.41
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.41
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.41
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.39
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.35
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.3
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.27
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 2.27
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 2.27
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.19
miRNAs affected by antagomiR-17 treatment 2.17
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.16
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.13
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.1
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.07
NAPRT activation of macrophages 2.02
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.01
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.96
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.95
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.95
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.93
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.93
A map of gene expression in neutrophil-like cell lines 1.91
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.9
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.9
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.9
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.89
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.85
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.79
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.78
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.76
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.73
circRNA-sequencing 1.72
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.71
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.65
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.59
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 1.58
Profiling of escape kinetics of viruses subjected to RNAi 1.57
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.56
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.46
BACH2 in human plasma cell fate decision 1.43
Regulation of hypoxia-inducible factor activity by ZMYND8 1.42
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.39
Clinker: visualizing fusion genes detected in RNA-seq data 1.38
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 1.37
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.33
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.31
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.31
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.29
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.29
Copper Regulation of HIF-1 Transcription Activity 1.27
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.27
Comparative Analysis of Cas9 Activators Across Multiple Species 1.19
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.18
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.17
Ribosome profiling upon inhibition of eIF4A 1.14
Downregulation of LATS kinases alters p53 to promote cell migration 1.08
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.07
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.05
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.05
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.02
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.0
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.99
Investigate A2M treatment on human prostate cancer and mouse liver 0.96
Investigate A2M treatment on human prostate cancer xenograft in mice 0.96
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.92
Deep RNA sequencing of the human placental transcriptome 0.92
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.89
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.84
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.81
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.81
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.8
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.78
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.78
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.75
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.71
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.65
H1609088 Human RNA-Sequencing 0.64
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.62
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.61
p63 controls the enhancer landscape during keratinocyte differentiation 0.6
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.59
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.59
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.55
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.51
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.51
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.5
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.5
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.49
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.46
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.45
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.43
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.4
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.4
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.35
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.28
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.28
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.21
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 0.2
The circadian transcriptional landscape in primary human mammary epithelial cells 0.2
MHC Transcriptomic landscape at haplotype-specific resolution 0.19
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.19
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.18
Expression profiling of converted and control dermal BJ fibroblasts 0.18
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.18
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.17
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.15
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.15
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.14
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.14
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.12
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.11
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.11
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.1
Energy Metabolism during Anchorage-Independence 0.09
RNA editing in nascent RNA affects pre-mRNA splicing 0.08
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.07
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.07
SRSF1 role in cellular gene expression and splicing 0.07
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.05
Enhancer activation during EGF response 0.04
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.04
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation